Effect of Integrated Care Involving Peripheral Functional Magnetic Stimulation for Sarcopenia
NCT ID: NCT06182020
Last Updated: 2023-12-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
80 participants
INTERVENTIONAL
2023-12-31
2025-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Integrated care
Participants in this group will receive both the peripheral functional magnetic stimulation to both the upper and lower limbs and nutritional supplement for consecutive 8 weeks.
Peripheral functional magnetic stimulation (ISKRA MEDICAL TESLA Former prestige Magneto therapy)
The peripheral functional magnetic stimulation will be conducted 30 minutes a session, 2 sessions per week, for consecutive 8 weeks. The stimulation will be placed over bilateral forearm flexor muscles and bilateral thighs over rectus femoris muscles.
Nutritional supplementation (ENSURE HIGH CALCIUM)
The nutritional supplementation includes 7 cans of "ENSURE HIGH CALCIUM" per week for 8 consecutive weeks.
Usual care
Participants in this group will receive an educational DVD and one session of oral instructions on general care and exercise suggestions for sarcopenia.
Education
The education includes a DVD and one session of oral instructions on general care and exercise suggestions for sarcopenia.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Peripheral functional magnetic stimulation (ISKRA MEDICAL TESLA Former prestige Magneto therapy)
The peripheral functional magnetic stimulation will be conducted 30 minutes a session, 2 sessions per week, for consecutive 8 weeks. The stimulation will be placed over bilateral forearm flexor muscles and bilateral thighs over rectus femoris muscles.
Nutritional supplementation (ENSURE HIGH CALCIUM)
The nutritional supplementation includes 7 cans of "ENSURE HIGH CALCIUM" per week for 8 consecutive weeks.
Education
The education includes a DVD and one session of oral instructions on general care and exercise suggestions for sarcopenia.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Can walk independently for over 15 minutes
* Diagnosed with possible sarcopenia or sarcopenia (by Asian Working Group for Sarcopenia: 2019 Consensus Update onSarcopenia Diagnosis and Treatment)
Exclusion Criteria
* History of cerebrovascular disease
* Deep vein thrombosis
* Malignancy under treatment
* Coagulopathy
* Serious orthopedic condition over limbs
* Inability to walk independently without assistive device
* Any other conditions not suggested to performance exercise
* Medical implants (e.g. pacemaker, defibrillator, deep brain nerve stimulation, infusion pump, etc.)
65 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Taiwan University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Shao-Yu Chi
Role: PRINCIPAL_INVESTIGATOR
National Taiwan University Hospital Bei-Hu Branch
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
National Taiwan University Hospital Bei-Hu Branch
Taipei, , Taiwan
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
202309121RIND
Identifier Type: -
Identifier Source: org_study_id